Form 483

DLC Laboratories, Inc. Form 483, 2018-03-30

FDA issued a Form 483 to DLC Laboratories, Inc. on 2018-03-30 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

DLC Laboratories, Inc. · Paramount, United States · Issued March 30, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Mar 2018
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Jolanna A Norton

30 Mar 2018
21 CFR 211.166(a)(2)

Stability sample storage conditions described

Cited by Jolanna A Norton

30 Mar 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Jolanna A Norton

30 Mar 2018
21 CFR 211.67(b)

Written procedures fail to include

Cited by Jolanna A Norton

Inspected site

DLDLC Laboratories, Inc.Paramount, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere